RxDoctor Payments DataLook up a doctor →

Sergio Jaramillo, MD

Sleep Medicine · Miami, FLNPI 1679770879

Payments from drug & device makers

$114,946in general payments, 2019–2025

Across 1,157 payments — averaging $99.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$66K
  • E.r. Squibb & Sons, L.L.C.$14K
  • AbbVie$8K
  • Alkermes, Inc.$4K
  • UCB, Inc.$4K
  • Pfizer$2K
  • plus $17K from 54 others
$105,823in research payments, 2019–2025

Across 11 payments — averaging $9620.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$106K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.137$65,810
E.r. Squibb & Sons, L.L.C.3$13,976
AbbVie(2 entities)164$7,950
Alkermes, Inc.16$4,309
UCB, Inc.110$4,014
Pfizer35$1,675
Abbott17$1,664
Inspire Medical Systems, Inc.16$1,368
Teva Pharmaceuticals USA, Inc.48$1,106
Amgen(2 entities)48$1,091
Neurocrine Biosciences, Inc.77$1,073
Eisai Inc.46$938
Lilly USA, LLC35$745
Harmony Biosciences LLC22$724
Novartis25$644
AstraZeneca(2 entities)13$529
Almatica Pharma LLC16$371
Tanabe Pharma America, Inc.13$348
Adamas Pharmaceuticals, Inc.26$329
Lundbeck LLC14$326
MDD US Operations, LLC17$310
Otsuka America Pharmaceutical, Inc.10$306
Argenx US, Inc.12$264
Johnson & Johnson(2 entities)8$257
SK Life Science, Inc.12$254
Merz Pharmaceuticals, LLC12$252
Axsome Therapeutics, Inc.12$246
Neurelis, Inc.13$245
Mallinckrodt Hospital Products Inc.7$241
Acorda Therapeutics, Inc13$235
Boston Scientific5$225
Biogen10$212
Amneal Pharmaceuticals LLC13$175
Sunovion Pharmaceuticals Inc.9$172
Avadel CNS Pharmaceuticals, LLC5$156
Octapharma USA, Inc.7$149
Biohaven Pharmaceuticals, Inc.8$148
TG Therapeutics, Inc.6$147
Insightec,inc1$139
Upsher-smith Laboratories LLC7$129
Sumitomo Pharma America, Inc.5$125
Biohaven Pharmaceutical Holding Company Ltd.8$124
Aprecia Pharmaceuticals, LLC6$115
Zyla Life Sciences, Inc.7$106
Genentech USA, Inc.4$96
Aquestive Therapeutics, Inc.5$95
Takeda Pharmaceuticals U.S.A., Inc.4$94
Grifols USA, LLC4$83
Banner Life Sciences, LLC4$78
Acadia Pharmaceuticals Inc4$77
Livanova USA, Inc.4$72
Kyowa Kirin, Inc.4$70
Bristol Myers Squibb3$50
Avion Pharmaceuticals3$49
Vanda Pharmaceuticals Inc.2$45
Greenwich Biosciences, Inc.2$39
C2n Diagnostics, LLC1$38
Cycle Pharmaceuticals Inc2$34
Philips North America LLC1$30
Averitas Pharma Inc.1$28

How this compares

$114,946 in reported general payments places this provider in the 85th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$137,923
Medicare patients
346
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →